tiprankstipranks
Immunic, Inc. (IMUX)
NASDAQ:IMUX
US Market
IMUX
Immunic
RESEARCH TOOLSreports
Want to see IMUX full AI Analyst Report?

Immunic (IMUX) Income Statement

2,243 Followers

Immunic Income Statement

Last quarter (Q1 2026), Immunic's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Immunic's net income was $-32.59M. See Immunic’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 103.23M$ 98.05M$ 99.22M$ 119.49M$ 91.67M
Depreciation and Amortization
$ 168.00K$ 134.00K$ 111.00K$ 77.00K$ 85.00K
EBITDA
$ -103.06M$ -97.92M$ -99.11M$ -86.44M$ -91.58M
Operating Income
$ -103.23M$ -98.05M$ -99.22M$ -119.49M$ -91.67M
Other Income/Expenses
$ 6.06M$ -2.46M$ 5.61M$ -919.00K$ -1.28M
Pretax Income
$ -97.17M$ -100.51M$ -93.61M$ -120.41M$ -92.94M
Net Income
$ -97.17M$ -100.51M$ -93.61M$ -120.41M$ -92.94M
Per Share Metrics
Basic EPS
$ -6.24$ -10.00$ -21.10$ -37.80$ -39.20
Diluted EPS
$ -6.24$ -10.00$ -21.10$ -37.80$ -39.20
Weighted Average Shares Outstanding
 15.57M- 4.43M--
Weighted Average Shares Outstanding (Diluted)
 15.57M- 4.43M--
Currency in USD

Immunic Earnings and Revenue History